Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)

Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)

NCT00048594 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)

NCT00035048 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)

NCT00034983 ·Status: COMPLETED ·Phase: PHASE3

Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)

NCT00610649 ·Status: COMPLETED ·Phase: PHASE2

A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication

NCT04937829 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder

NCT01380704 ·Status: COMPLETED ·Phase: PHASE1

This is a Study to Determine the Antidepressant Effects of AZD6765

NCT00986479 ·Status: COMPLETED ·Phase: PHASE2

A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression

NCT01098240 ·Status: TERMINATED ·Phase: PHASE2

Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

NCT01741142 ·Status: TERMINATED ·Phase: PHASE2

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

NCT06786624 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)

NCT04663321 ·Status: TERMINATED ·Phase: PHASE2

A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

NCT06785012 ·Status: RECRUITING ·Phase: PHASE2

Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

NCT06966401 ·Status: RECRUITING ·Phase: PHASE3

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

NCT01111539 ·Status: TERMINATED ·Phase: PHASE3

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

NCT00969709 ·Status: COMPLETED ·Phase: PHASE3

A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder

NCT00733980 ·Status: COMPLETED ·Phase: PHASE2

Antidepressant Effects of NR2B in Major Depression

NCT00472576 ·Status: COMPLETED ·Phase: PHASE1

Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder

NCT00593879 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

NCT01111552 ·Status: TERMINATED ·Phase: PHASE3

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

NCT06911112 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

NCT01436149 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder

NCT01034462 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Memantine for Major Depression

NCT00040261 ·Status: COMPLETED ·Phase: PHASE3

Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder

NCT01667926 ·Status: COMPLETED ·Phase: NA

Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder

NCT02362529 ·Status: COMPLETED ·Phase: EARLY_PHASE1